Exoribonuclease in nonstructural protein 14 (nsp14-ExoN)

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In vitro studies suggest nsp14-ExoN inhibitors could help sensitize coronaviruses to RNA mutagen therapeutics including ribavirin.

Related collections

Author and article information

Journal

Title: Science-Business eXchange

Publisher: Nature Publishing Group US (New York )

ISSN (Electronic): 1945-3477

Publication date (Print): 2013

Volume: 6

Issue: 36

Page: 998

Article

Publisher ID: BFscibx2013998

DOI: 10.1038/scibx.2013.998

PMC ID: 7149067

SO-VID: d2ead3c7-6bee-437d-be73-916ec65d1bd5

License:

This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

History

Custom metadata

Data availability:

Comments

Comment on this article

scite_